Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01567618
Recruitment Status : Completed
First Posted : March 30, 2012
Last Update Posted : November 7, 2014
Information provided by (Responsible Party):
Jian Xiao, Sixth Affiliated Hospital, Sun Yat-sen University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2013
  Study Completion Date : April 2014